Published in Schizophr Bull on August 04, 2005
Genes for schizophrenia and bipolar disorder? Implications for psychiatric nosology. Schizophr Bull (2005) 3.93
Bipolar I disorder and schizophrenia: a 440-single-nucleotide polymorphism screen of 64 candidate genes among Ashkenazi Jewish case-parent trios. Am J Hum Genet (2005) 3.03
Validity of the prodromal risk syndrome for first psychosis: findings from the North American Prodrome Longitudinal Study. Schizophr Bull (2009) 2.90
Rethinking psychosis: the disadvantages of a dichotomous classification now outweigh the advantages. World Psychiatry (2007) 2.82
DISC1 regulates new neuron development in the adult brain via modulation of AKT-mTOR signaling through KIAA1212. Neuron (2009) 2.72
The genetic deconstruction of psychosis. Schizophr Bull (2007) 2.25
Neuregulin 1 ICE-single nucleotide polymorphism in first episode schizophrenia correlates with cerebral activation in fronto-temporal areas. Eur Arch Psychiatry Clin Neurosci (2008) 1.55
Interactions among genes in the ErbB-Neuregulin signalling network are associated with increased susceptibility to schizophrenia. Behav Brain Funct (2007) 1.19
Dysbindin-1 mutant mice implicate reduced fast-phasic inhibition as a final common disease mechanism in schizophrenia. Proc Natl Acad Sci U S A (2011) 1.15
Genes and schizophrenia: beyond schizophrenia: the role of DISC1 in major mental illness. Schizophr Bull (2006) 1.12
In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia. Schizophr Res (2009) 1.12
Evidence of missense mutations on the neuregulin 1 gene affecting function of prepulse inhibition. Biol Psychiatry (2007) 1.06
Comparing genes and phenomenology in the major psychoses: schizophrenia and bipolar 1 disorder. Schizophr Bull (2008) 1.03
Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Front Mol Neurosci (2011) 1.00
Neuregulin 1-erbB4 pathway in schizophrenia: From genes to an interactome. Brain Res Bull (2010) 0.97
Association study of CSF2RB with schizophrenia in Irish family and case - control samples. Mol Psychiatry (2007) 0.95
Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia. Schizophr Res (2007) 0.94
Is the histidine triad nucleotide-binding protein 1 (HINT1) gene a candidate for schizophrenia? Schizophr Res (2008) 0.93
MEGF10 association with schizophrenia. Biol Psychiatry (2008) 0.89
Schizophrenia: an integrative approach to modelling a complex disorder. J Psychiatry Neurosci (2006) 0.89
Biomarkers of bipolar disorder: specific or shared with schizophrenia? Front Biosci (Elite Ed) (2013) 0.86
Genetic associations between neuregulin-1 SNPs and neurocognitive function in multigenerational, multiplex schizophrenia families. Psychiatr Genet (2012) 0.86
Neuregulin 1: a prime candidate for research into gene-environment interactions in schizophrenia? Insights from genetic rodent models. Front Behav Neurosci (2013) 0.85
Social cognitive role of schizophrenia candidate gene GABRB2. PLoS One (2013) 0.83
Lack of association to a NRG1 missense polymorphism in schizophrenia or bipolar disorder in a Costa Rican population. Schizophr Res (2011) 0.83
Imaging genetics of structural brain connectivity and neural integrity markers. Neuroimage (2009) 0.83
What does a mouse tell us about neuregulin 1-cannabis interactions? Front Cell Neurosci (2013) 0.82
Gene expression of NMDA receptor subunits in the cerebellum of elderly patients with schizophrenia. Eur Arch Psychiatry Clin Neurosci (2009) 0.82
A Study of the Association between SNP8NRG241930 in the 5' End of Neuroglin 1 Gene with Schizophrenia in a Group of Iranian Patients. Cell J (2011) 0.79
Clinical impact of recently detected susceptibility genes for schizophrenia. Dialogues Clin Neurosci (2006) 0.78
Global signaling effects of a schizophrenia-associated missense mutation in neuregulin 1: an exploratory study using whole genome and novel kinome approaches. J Neural Transm (Vienna) (2014) 0.78
Using human brain imaging studies as a guide toward animal models of schizophrenia. Neuroscience (2015) 0.76
Molecular genetics of the psychosis phenotype. Can J Psychiatry (2012) 0.75
Gene × Environment Interactions in Schizophrenia: Evidence from Genetic Mouse Models. Neural Plast (2016) 0.75
Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes: principal results of the Conduit Artery Function Evaluation (CAFE) study. Circulation (2006) 10.05
Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet (2013) 7.44
Failure to detect the novel retrovirus XMRV in chronic fatigue syndrome. PLoS One (2010) 4.66
Heterogeneity in incidence rates of schizophrenia and other psychotic syndromes: findings from the 3-center AeSOP study. Arch Gen Psychiatry (2006) 3.35
Incidence of schizophrenia and other psychoses in ethnic minority groups: results from the MRC AESOP Study. Psychol Med (2006) 2.79
High-potency cannabis and the risk of psychosis. Br J Psychiatry (2009) 2.41
Gene variants associated with schizophrenia in a Norwegian genome-wide study are replicated in a large European cohort. J Psychiatr Res (2010) 1.98
Reliability and comparability of psychosis patients' retrospective reports of childhood abuse. Schizophr Bull (2009) 1.94
Impact of statin therapy on central aortic pressures and hemodynamics: principal results of the Conduit Artery Function Evaluation-Lipid-Lowering Arm (CAFE-LLA) Study. Circulation (2008) 1.88
Is impaired set-shifting an endophenotype of anorexia nervosa? Am J Psychiatry (2005) 1.86
Regional gray matter volume abnormalities in the at risk mental state. Biol Psychiatry (2006) 1.81
Increased pituitary volume in antipsychotic-free and antipsychotic-treated patients of the AEsop first-onset psychosis study. Neuropsychopharmacology (2005) 1.76
Ethnic differences in blood pressure response to first and second-line antihypertensive therapies in patients randomized in the ASCOT Trial. Am J Hypertens (2010) 1.75
Self-harm in first-episode psychosis. Br J Psychiatry (2008) 1.72
Pituitary volume in psychosis. Br J Psychiatry (2004) 1.70
Parental separation, loss and psychosis in different ethnic groups: a case-control study. Psychol Med (2007) 1.64
Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users. Biol Psychiatry (2012) 1.64
Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial. Arthritis Rheum (2002) 1.62
Randomized controlled trials of autologous hematopoietic stem cell transplantation for autoimmune diseases: the evolution from myeloablative to lymphoablative transplant regimens. Arthritis Rheum (2006) 1.62
Altered immune phenotype in peripheral blood cells of patients with scleroderma-associated pulmonary hypertension. Clin Transl Sci (2010) 1.56
Recombinant human relaxin in the treatment of systemic sclerosis with diffuse cutaneous involvement: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum (2009) 1.53
Clinical and social determinants of duration of untreated psychosis in the AESOP first-episode psychosis study. Br J Psychiatry (2006) 1.53
Abnormal cortisol levels during the day and cortisol awakening response in first-episode psychosis: the role of stress and of antipsychotic treatment. Schizophr Res (2009) 1.48
A dopamine transporter gene functional variant associated with cocaine abuse in a Brazilian sample. Proc Natl Acad Sci U S A (2006) 1.40
First episode psychosis and ethnicity: initial findings from the AESOP study. World Psychiatry (2006) 1.39
Neighbourhood-level effects on psychoses: re-examining the role of context. Psychol Med (2007) 1.38
Effects of the CACNA1C risk allele for bipolar disorder on cerebral gray matter volume in healthy individuals. Am J Psychiatry (2009) 1.35
A 3-Mb map of a large Segmental duplication overlapping the alpha7-nicotinic acetylcholine receptor gene (CHRNA7) at human 15q13-q14. Genomics (2002) 1.31
Gender differences in the association between childhood abuse and psychosis. Br J Psychiatry (2009) 1.30
Metabolic syndrome and autoimmune diabetes: action LADA 3. Diabetes Care (2008) 1.27
Pituitary volume predicts future transition to psychosis in individuals at ultra-high risk of developing psychosis. Biol Psychiatry (2005) 1.24
The dietary pattern of patients with schizophrenia: a systematic review. J Psychiatr Res (2012) 1.23
Trials within trials? Researcher, funder and ethical perspectives on the practicality and acceptability of nesting trials of recruitment methods in existing primary care trials. BMC Med Res Methodol (2010) 1.22
Specific and generalized neuropsychological deficits: a comparison of patients with various first-episode psychosis presentations. Am J Psychiatry (2009) 1.20
Structural brain abnormalities in individuals with an at-risk mental state who later develop psychosis. Br J Psychiatry Suppl (2007) 1.16
White matter integrity as a predictor of response to treatment in first episode psychosis. Brain (2013) 1.16
Power calculations for multicenter imaging studies controlled by the false discovery rate. Hum Brain Mapp (2010) 1.13
Higher cortisol levels are associated with smaller left hippocampal volume in first-episode psychosis. Schizophr Res (2010) 1.13
Molecular and genetic evidence for abnormalities in the nodes of Ranvier in schizophrenia. Arch Gen Psychiatry (2011) 1.12
Replication of association of 3p21.1 with susceptibility to bipolar disorder but not major depression. Nat Genet (2011) 1.10
Duration of untreated psychosis and ethnicity in the AESOP first-onset psychosis study. Psychol Med (2005) 1.09
Cortical folding defects as markers of poor treatment response in first-episode psychosis. JAMA Psychiatry (2013) 1.08
Gray matter abnormalities associated with duration of untreated psychosis. Schizophr Res (2006) 1.07
Perceptions of disadvantage, ethnicity and psychosis. Br J Psychiatry (2008) 1.03
MQX-503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: a randomized, controlled trial. Arthritis Rheum (2009) 1.03
Serum and gene expression profile of cytokines in first-episode psychosis. Brain Behav Immun (2012) 1.02
Association between symptom dimensions and categorical diagnoses of psychosis: a cross-sectional and longitudinal investigation. Schizophr Bull (2013) 1.01
Investigation into the presence of and serological response to XMRV in CFS patients. PLoS One (2011) 1.01
Neighbourhood variation in the incidence of psychotic disorders in Southeast London. Soc Psychiatry Psychiatr Epidemiol (2007) 1.00
The effects of gender and COMT Val158Met polymorphism on fearful facial affect recognition: a fMRI study. Int J Neuropsychopharmacol (2008) 0.99
Stargazin involvement with bipolar disorder and response to lithium treatment. Pharmacogenet Genomics (2008) 0.99
A common variant in DRD3 receptor is associated with autism spectrum disorder. Biol Psychiatry (2008) 0.98
Hypothalamic-pituitary-adrenal axis and clinical symptoms in first-episode psychosis. Psychoneuroendocrinology (2011) 0.98
Neurological soft signs are not "soft" in brain structure and functional networks: evidence from ALE meta-analysis. Schizophr Bull (2013) 0.97
Ambulatory blood pressure monitoring predicts cardiovascular events in treated hypertensive patients--an Anglo-Scandinavian cardiac outcomes trial substudy. J Hypertens (2009) 0.96
Dissociable brain structural changes associated with predisposition, resilience, and disease expression in bipolar disorder. J Neurosci (2009) 0.96
Childhood emotional problems and self-perceptions predict weight gain in a longitudinal regression model. BMC Med (2009) 0.94
Correlation-based multivariate analysis of genetic influence on brain volume. Neurosci Lett (2008) 0.93
Association study of dysbindin gene with clinical and outcome measures in a representative cohort of Italian schizophrenic patients. Am J Med Genet B Neuropsychiatr Genet (2007) 0.93
COMT, neuropsychological function and brain structure in schizophrenia: a systematic review and neurobiological interpretation. J Psychiatry Neurosci (2013) 0.93
Association study of the INPP1, 5HTT, BDNF, AP-2beta and GSK-3beta GENE variants and restrospectively scored response to lithium prophylaxis in bipolar disorder. Neurosci Lett (2006) 0.93
Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort. J Clin Rheumatol (2013) 0.93
Incidence of bipolar affective disorder in three UK cities: results from the AESOP study. Br J Psychiatry (2005) 0.92
Association of DAO and G72(DAOA)/G30 genes with bipolar affective disorder. Am J Med Genet B Neuropsychiatr Genet (2008) 0.92
Caregiving in first-episode psychosis: social characteristics associated with perceived 'burden' and associations with compulsory treatment. Early Interv Psychiatry (2013) 0.92
Acute effects of single-dose aripiprazole and haloperidol on resting cerebral blood flow (rCBF) in the human brain. Hum Brain Mapp (2012) 0.91
Association of the dysbindin gene with bipolar affective disorder. Am J Psychiatry (2006) 0.91
The Neuro/PsyGRID calibration experiment: identifying sources of variance and bias in multicenter MRI studies. Hum Brain Mapp (2011) 0.91
Present and lifetime comorbidity of tobacco, alcohol and drug use in eating disorders: a European multicenter study. Drug Alcohol Depend (2008) 0.91
Ethnic identity, perceptions of disadvantage, and psychosis: findings from the ÆSOP study. Schizophr Res (2010) 0.91
Neurological soft signs discriminate schizophrenia from major depression but not bipolar disorder. Prog Neuropsychopharmacol Biol Psychiatry (2012) 0.91
Duration of prodromal phase and severity of volumetric abnormalities in first-episode psychosis. Br J Psychiatry Suppl (2007) 0.90
Two peptidase activities decrease in treated bipolar disorder not schizophrenic patients. Bipolar Disord (2004) 0.90
Duration of untreated psychosis and neuropsychological function in first episode psychosis. Schizophr Res (2007) 0.90
Positional pathway screen of wnt signaling genes in schizophrenia: association with DKK4. Biol Psychiatry (2007) 0.89
Use of a validated algorithm to estimate the annual cost of effective biologic treatment for rheumatoid arthritis. J Med Econ (2014) 0.89
The psychopathology of schizophrenia and the presence of neurological soft signs: a review. Curr Opin Psychiatry (2005) 0.89
Unemployment, social isolation, achievement-expectation mismatch and psychosis: findings from the AESOP Study. Soc Psychiatry Psychiatr Epidemiol (2008) 0.89
No association between a common single nucleotide polymorphism, rs4141463, in the MACROD2 gene and autism spectrum disorder. Am J Med Genet B Neuropsychiatr Genet (2011) 0.89
Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls. Schizophr Res (2013) 0.88
Translating the epidemiology of psychosis into public mental health: evidence, challenges and future prospects. J Public Ment Health (2010) 0.88
Candidate gene analysis of the human natural killer-1 carbohydrate pathway and perineuronal nets in schizophrenia: B3GAT2 is associated with disease risk and cortical surface area. Biol Psychiatry (2010) 0.88
Low social interactions in eating disorder patients in childhood and adulthood: a multi-centre European case control study. J Health Psychol (2012) 0.88
Pituitary volume in unaffected relatives of patients with schizophrenia and bipolar disorder. Psychoneuroendocrinology (2008) 0.88
A genome-wide association analysis of a broad psychosis phenotype identifies three loci for further investigation. Biol Psychiatry (2013) 0.87
Linkage disequilibrium analysis of the CHRNA7 gene and its partially duplicated region in schizophrenia. Neurosci Res (2006) 0.87
Assessment of the impact of the scanner-related factors on brain morphometry analysis with Brainvisa. BMC Med Imaging (2011) 0.86
Ten-Year Outcomes of First-Episode Psychoses in the MRC ÆSOP-10 Study. J Nerv Ment Dis (2015) 0.86
Insight, grey matter and cognitive function in first-onset psychosis. Br J Psychiatry (2010) 0.86
The differential clinical and neurocognitive profiles of COMT SNP rs165599 genotypes in schizophrenia. J Int Neuropsychol Soc (2005) 0.86
Childhood trauma and cognitive function in first-episode affective and non-affective psychosis. Schizophr Res (2011) 0.86
Further evaluation of a claims-based algorithm to determine the effectiveness of biologics for rheumatoid arthritis using commercial claims data. Arthritis Res Ther (2013) 0.86
Set shifting and central coherence as neurocognitive endophenotypes in eating disorders: a preliminary investigation in twins. World J Biol Psychiatry (2012) 0.86
Is there a link between childhood trauma, cognition, and amygdala and hippocampus volume in first-episode psychosis? Schizophr Res (2012) 0.85
Social disadvantage: cause or consequence of impending psychosis? Schizophr Bull (2012) 0.85
Grey matter abnormalities in first-episode schizophrenia and affective psychosis. Br J Psychiatry Suppl (2007) 0.85
Nuclear receptor rev-erb-{alpha} circadian gene variants and lithium carbonate prophylaxis in bipolar affective disorder. J Biol Rhythms (2010) 0.85
High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial: lessons learned. Semin Arthritis Rheum (2004) 0.85
Do illness characteristics and familial risk differ between women with anorexia nervosa grouped on the basis of personality pathology? Psychol Med (2005) 0.84
CHRFAM7A copy number and 2-bp deletion polymorphisms and antisaccade performance. Int J Neuropsychopharmacol (2009) 0.84